Brainstorm Cell Therapeutics Inc.

NasdaqCM:BCLI Stock Report

Market Cap: US$12.7m

Brainstorm Cell Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BCLI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Oct 24BuyUS$6,292Chaim LebovitsIndividual1,836US$3.43
19 Jul 24SellUS$22,069Ibrahim DagherIndividual4,200US$5.25
28 May 24BuyUS$7,774Chaim LebovitsIndividual1,000US$7.77
22 May 24BuyUS$30,475Chaim LebovitsIndividual3,333.34US$9.60
13 May 24BuyUS$18,865Chaim LebovitsIndividual2,666.67US$7.35
07 May 24BuyUS$75,482Chaim LebovitsIndividual13,420.01US$5.63
19 Apr 24BuyUS$7,798Chaim LebovitsIndividual1,000US$7.80
18 Apr 24BuyUS$131,411Chaim LebovitsIndividual16,338.14US$8.19

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCLI?
Owner TypeNumber of SharesOwnership Percentage
Private Companies133,3892.34%
Institutions272,3594.78%
Individual Insiders425,5357.46%
Hedge Funds538,9309.45%
General Public4,333,21376%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 74.7%.

Top Shareholders

Top 25 shareholders own 23.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.45%
Armistice Capital LLC
538,930US$1.2m2.1%0.03%
4.84%
Matthew Ruck
275,838US$615.1k0%no data
2.26%
ACCBT Corporation
128,919US$287.5k0%no data
1.77%
The Vanguard Group, Inc.
100,709US$224.6k0%no data
1.42%
Chaim Lebovits
80,960US$180.5k4.25%no data
0.8%
Geode Capital Management, LLC
45,521US$101.5k41%no data
0.44%
BlackRock, Inc.
25,174US$56.1k-2.27%no data
0.42%
Stacy Lindborg
24,146US$53.8k-14.5%no data
0.4%
Liberty Wealth Management, LLC
22,676US$50.6k0%0.01%
0.27%
Weaver Consulting Group, LLC
15,623US$34.8k0%0.01%
0.22%
Ibrahim Dagher
12,667US$28.2k-24.9%no data
0.18%
Irit Arbel
10,389US$23.2k0%no data
0.17%
Abner Herrman & Brock, LLC
9,700US$21.6k0%no data
0.15%
Uri Yablonka
8,465US$18.9k0%no data
0.14%
State Street Global Advisors, Inc.
7,817US$17.4k0%no data
0.13%
Northern Trust Global Investments
7,490US$16.7k0%no data
0.11%
Raymond James Financial Inc., Asset Management Arm
6,343US$14.1k-14.5%no data
0.078%
ACC International Holdings Ltd.
4,470US$10.0k0%no data
0.076%
JMAC Enterprises LLC
4,362US$9.7k0%no data
0.076%
Alla Patlis
4,350US$9.7k0%no data
0.066%
Jacob Frenkel
3,778US$8.4k0%no data
0.062%
XTX Holdings Limited, Asset Management Arm
3,539US$7.9k0%no data
0.062%
Wells Fargo & Company, Securities and Brokerage Investments
3,518US$7.8k83.2%no data
0.058%
Morgan Stanley, Investment Banking and Brokerage Investments
3,297US$7.4k33.8%no data
0.055%
Group One Trading LP, Asset Management Arm
3,116US$6.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 04:00
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Brainstorm Cell Therapeutics Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullACF Equity Research Limited
Jason KolbertH.C. Wainwright & Co.
Jason McCarthyMaxim Group